WASHINGTON — The United States Conference of Catholic Bishops (USCCB) last week launched a nationwide two-week ad campaign highlighting the issue of stem cell research. The ads draw a clear distinction between embryonic stem-cell research, which requires the destruction of human life at the embryonic stage, and adult stem-cell research.
“Stem cell research is one of the most important moral issues of our day, but it is also one of the most distorted,” said Cathy Cleaver Ruse, Esq., Director of Planning and Information for the USCCB's Secretariat for Pro-Life Activities. “In the public debate, embryo-destructive research has been greatly hyped, while the proven results of ethical adult stem cell research are very nearly ignored.”
“Our ads explain that adult stem-cell research is already helping people with heart disease, spinal cord injury, Parkinson's, and many other diseases. Embryonic stem cells, on the other hand, have not helped one single human patient, and they come with a hefty price tag: the deliberate destruction of human life,” Ruse said. “As our ads state: science does not have to kill in order to cure.”
The ads will appear in USA Today, the Washington Times, and the National Catholic Reporter. The ads have also gone to dioceses nationwide for use in local publications.
(This update courtesy of LifeSiteNews.com.)
